Artificial Intelligence Detects Cardiac Amyloidosis Before Clinical Diagnosis
Yuan, V.; Kalagara, S.; IEKI, H.; Bhatt, A. S.; Ambrosy, A. P.; Elezaby, A.; Stern, L. K.; Cheng, P.; Ouyang, D.
Show abstract
The approval of novel disease-modifying treatments for cardiac amyloidosis (CA) offers an avenue to stabilize disease progression. Timely diagnosis of CA is imperative so that patients can be connected to treatment earlier in their course. Echocardiography is a widely available, non-invasive modality to screen for CA. However, diagnosis of CA is often delayed due to phenotypic mimickers. Artificial intelligence (AI) applied to echocardiography may facilitate early detection and connect patients to more definitive diagnostic testing. In this case report, we analyzed the frequency of echocardiography prior to clinical diagnosis of amyloidosis and deployed an externally validated AI model in 349 patients with documented amyloidosis at Cedars-Sinai Medical Center. On average, AI detection was positive in patients with documented CA 218 days prior to clinical diagnosis and 209 days in all-comers. When integrated with clinical histories, AI may facilitate earlier detection of CA and connect patients to more timely management.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Predicting 30-Day and 1-Year Mortality in Heart Failure with Preserved Ejection Fraction (HFpEF) 91%
- External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure 90%
- Translation of Immunomodulatory Therapy to Treat Chronic Heart Failure: Preclinical Studies to First in Human 90%
Similar papers in this journal
- Prognostic value of compact myocardial thinning in patients with left ventricular non-compaction 90%
- Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions 90%
- Investigating Electrocardiographic Abnormalities in Patients with Coronary Microvascular Dysfunction 90%
Similar papers in this journal
Similar papers in this journal
- The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20 Center Retrospective Cohort Study 91%
- Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis 90%
- Arrhythmia and Survival Outcomes among Black and White Patients with a Primary Prevention Defibrillator 88%
Similar papers in this journal
- Kidney Function Assessment Using Cystatin C and Serum Creatinine in Heart Transplantation Recipients: Implications for Valganciclovir Dosing 89%
- Relationship Between Donor Derived Cell-Free DNA and Tissue-Based Rejection-Related Transcripts In Heart Transplantation 89%
- Advanced Hemodynamic and Cluster Analysis for Identifying Novel RV function subphenotypes in Patients with Pulmonary Hypertension 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.